These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

325 related articles for article (PubMed ID: 21756549)

  • 41. Predictive factors for early clinical improvement after intra-arterial thrombolytic therapy in acute ischemic stroke.
    Jeong HS; Kwon HJ; Kang CW; Song HJ; Koh HS; Park SM; Lim JG; Shin JE; Lee SH; Kim J
    J Stroke Cerebrovasc Dis; 2014 Apr; 23(4):e283-9. PubMed ID: 24529352
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Safety of intravenous thrombolysis in acute ischemic stroke patients with saccular intracranial aneurysms.
    Mittal MK; Seet RC; Zhang Y; Brown RD; Rabinstein AA
    J Stroke Cerebrovasc Dis; 2013 Jul; 22(5):639-43. PubMed ID: 22341666
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Factors predicting outcome in stroke patients treated with 0.6 mg/kg alteplase: evidence from the Japan Alteplase Clinical Trial (J-ACT).
    Mori E; Minematsu K; Nakagawara J; Yamaguchi T;
    J Stroke Cerebrovasc Dis; 2011 Nov; 20(6):517-22. PubMed ID: 20719535
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Renal impairment reduces the efficacy of thrombolytic therapy in acute ischemic stroke.
    Power A; Epstein D; Cohen D; Bathula R; Devine J; Kar A; Taube D; Duncan N; Ames D
    Cerebrovasc Dis; 2013; 35(1):45-52. PubMed ID: 23428996
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Tissue plasminogen activator thrombolytic therapy for acute ischemic stroke in 4 hospital groups in Japan.
    Kono S; Deguchi K; Morimoto N; Kurata T; Deguchi S; Yamashita T; Ikeda Y; Matsuura T; Narai H; Omori N; Manabe Y; Yunoki T; Takao Y; Kawata S; Kashihara K; Abe K
    J Stroke Cerebrovasc Dis; 2013 Apr; 22(3):190-6. PubMed ID: 21968092
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Intravenous thrombolysis with rt-PA in acute ischemic stroke patients aged older than 80 years in Italy.
    Toni D; Lorenzano S; Agnelli G; Guidetti D; Orlandi G; Semplicini A; Toso V; Caso V; Malferrari G; Fanucchi S; Bartolomei L; Prencipe M
    Cerebrovasc Dis; 2008; 25(1-2):129-35. PubMed ID: 18073466
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Early ischemic change on CT versus diffusion-weighted imaging for patients with stroke receiving intravenous recombinant tissue-type plasminogen activator therapy: stroke acute management with urgent risk-factor assessment and improvement (SAMURAI) rt-PA registry.
    Nezu T; Koga M; Nakagawara J; Shiokawa Y; Yamagami H; Furui E; Kimura K; Hasegawa Y; Okada Y; Okuda S; Kario K; Naganuma M; Maeda K; Minematsu K; Toyoda K
    Stroke; 2011 Aug; 42(8):2196-200. PubMed ID: 21719764
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Intravenous thrombolysis for acute ischemic stroke.
    Turc G; Isabel C; Calvet D
    Diagn Interv Imaging; 2014 Dec; 95(12):1129-33. PubMed ID: 25465121
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Extent of early ischemic changes on computed tomography (CT) before thrombolysis: prognostic value of the Alberta Stroke Program Early CT Score in ECASS II.
    Dzialowski I; Hill MD; Coutts SB; Demchuk AM; Kent DM; Wunderlich O; von Kummer R
    Stroke; 2006 Apr; 37(4):973-8. PubMed ID: 16497977
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Susceptibility-weighted imaging for cerebral microbleed detection in super-acute ischemic stroke patients treated with intravenous thrombolysis.
    Bai Q; Zhao Z; Sui H; Xie X; Chen J; Yang J; Zhang L
    Neurol Res; 2013 Jul; 35(6):586-93. PubMed ID: 23561793
    [TBL] [Abstract][Full Text] [Related]  

  • 51. NOR-SASS (Norwegian Sonothrombolysis in Acute Stroke Study): Randomized Controlled Contrast-Enhanced Sonothrombolysis in an Unselected Acute Ischemic Stroke Population.
    Nacu A; Kvistad CE; Naess H; Øygarden H; Logallo N; Assmus J; Waje-Andreassen U; Kurz KD; Neckelmann G; Thomassen L
    Stroke; 2017 Feb; 48(2):335-341. PubMed ID: 27980128
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Intravenous tissue-type plasminogen activator for treatment of acute stroke: the Standard Treatment with Alteplase to Reverse Stroke (STARS) study.
    Albers GW; Bates VE; Clark WM; Bell R; Verro P; Hamilton SA
    JAMA; 2000 Mar; 283(9):1145-50. PubMed ID: 10703776
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Transition of European Cooperative Acute Stroke Study III results to clinical practice: ninety-day outcomes in a US cohort.
    Cronin CA; Langenberg P; Dutta TM; Kittner SJ
    Stroke; 2013 Dec; 44(12):3544-6. PubMed ID: 24092551
    [TBL] [Abstract][Full Text] [Related]  

  • 54. An observational study of thrombolysis outcomes in wake-up ischemic stroke patients.
    Manawadu D; Bodla S; Keep J; Jarosz J; Kalra L
    Stroke; 2013 Feb; 44(2):427-31. PubMed ID: 23287781
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Outcome and severe hemorrhagic complications of intravenous thrombolysis with tissue plasminogen activator in very old (> or =80 years) stroke patients.
    Berrouschot J; Röther J; Glahn J; Kucinski T; Fiehler J; Thomalla G
    Stroke; 2005 Nov; 36(11):2421-5. PubMed ID: 16210554
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Thrombolytic therapy for acute ischemic stroke after recent transient ischemic attack.
    Alonso de Leciñana M; Fuentes B; Masjuan J; Simal P; Díaz-Otero F; Reig G; Díez-Tejedor E; Gil-Nuñez A; Vivancos J; Egido JA
    Int J Stroke; 2012 Apr; 7(3):213-8. PubMed ID: 22098785
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Internal cerebral vein asymmetry on follow-up brain computed tomography after intravenous thrombolysis in acute anterior circulation ischemic stroke is associated with poor outcome.
    Sharma VK; Yeo LL; Teoh HL; Shen L; Chan BP; Seet RC; Ahmad A; Chong VF; Paliwal PR
    J Stroke Cerebrovasc Dis; 2014 Jan; 23(1):e39-45. PubMed ID: 24119628
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Intraarterial thrombolytic therapy within 3 hours of the onset of stroke.
    Bourekas EC; Slivka AP; Shah R; Sunshine J; Suarez JI
    Neurosurgery; 2004 Jan; 54(1):39-44; discussion 44-6. PubMed ID: 14683539
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Symptomatic intracranial hemorrhage following intravenous thrombolysis for acute ischemic stroke: a critical review of case definitions.
    Seet RC; Rabinstein AA
    Cerebrovasc Dis; 2012; 34(2):106-14. PubMed ID: 22868870
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Alteplase at 0.6 mg/kg for acute ischemic stroke within 3 hours of onset: Japan Alteplase Clinical Trial (J-ACT).
    Yamaguchi T; Mori E; Minematsu K; Nakagawara J; Hashi K; Saito I; Shinohara Y;
    Stroke; 2006 Jul; 37(7):1810-5. PubMed ID: 16763187
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 17.